December 19, 2011
Associate professor Tim Wiltshire, PhD, has received tenure at the UNC Eshelman School of Pharmacy.
Wiltshire joined the School’s Division of Pharmacotherapy and Experimental Therapeutics in 2007. He serves as the associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy. He also holds adjunct faculty positions in the UNC Lineberger Comprehensive Cancer Center and in theDepartment of Genetics at the UNC School of Medicine. In addition, he is actively involved in several collaborations with the Hamner Institutes for Health Sciences.
Before coming to UNC, Wiltshire was a senior research investigator at the Genomics Institute of the Novartis Research Foundation. Before that, he spent eleven years as a high school biology teacher in New Zealand before changing direction and going into research.
Wiltshire studies drug reactions using mouse models with different genetic makeups. His current focus is on anxiety and depression and the medications used to treat them. His work is being supported by a grant from the National Institute of Mental Health.
“Dr. Wiltshire has made valuable contributions to the School since he joined us four years ago,” says Bob Blouin, PharmD, dean of the School. “His work covers an important area in our quest to match medicines with the unique genetic makeup of the people who need them.”
Wiltshire is a member of the American Association for Advancement of Science and the American Society of Human Genetics, and an elected member of the Nominations committee of the International Mouse Genome Society. He is the author of more than seventy publications in refereed journals and more than thirty books and book chapters. In 2009 he received a best-paper award from the Society of Toxicology for a publication in Genome Research.
Latest News
Dean Angela Kashuba receives Carolina Alumni Faculty Service Award
RASP poster presentations capture student research
